CONMED Corp. (CNMD)

80.58
0.77 0.96
NASDAQ : Health Technology
Prev Close 79.81
Open 79.94
Day Low/High 78.63 / 80.76
52 Wk Low/High 56.91 / 83.49
Volume 134.90K
Avg Volume 317.00K
Exchange NASDAQ
Shares Outstanding 28.15M
Market Cap 2.22B
EPS 1.40
P/E Ratio 55.96
Div & Yield 0.80 (1.03%)

Latest News

CONMED Corporation To Present At The SVB Leerink Global Healthcare Conference

CONMED Corporation To Present At The SVB Leerink Global Healthcare Conference

CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W.

CONMED Completes Acquisition Of Buffalo Filter LLC

CONMED Completes Acquisition Of Buffalo Filter LLC

CONMED Corporation (NASDAQ: CNMD) today announced that it has completed its previously announced acquisition of privately-held Buffalo Filter LLC (Buffalo Filter) from Filtration Group.

CONMED Corporation Announces Pricing Of $300 Million Offering Of Convertible Senior Notes

CONMED Corporation Announces Pricing Of $300 Million Offering Of Convertible Senior Notes

CONMED Corporation (NASDAQ: CNMD) today announced the pricing of $300.0 million aggregate principal amount of 2.

CONMED Corporation Announces Private Offering Of $275 Million Of Convertible Senior Notes

CONMED Corporation Announces Private Offering Of $275 Million Of Convertible Senior Notes

CONMED Corporation (NASDAQ: CNMD) today announced that it intends to offer, subject to market conditions and other factors, $275 million aggregate principal amount of its convertible senior notes due 2024 in a private offering to qualified institutional...

CONMED Corporation Announces Fourth Quarter And Full-Year 2018 Financial Results

CONMED Corporation Announces Fourth Quarter And Full-Year 2018 Financial Results

CONMED Corporation (Nasdaq: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2018.

CONMED Corporation To Announce Fourth Quarter And Fiscal Year 2018 Financial Results On January 22, 2019

CONMED Corporation To Announce Fourth Quarter And Fiscal Year 2018 Financial Results On January 22, 2019

CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the fourth quarter and fiscal year 2018 after the market close on Tuesday, January 22, 2019.

CONMED Corporation To Present At The J.P. Morgan Healthcare Conference

CONMED Corporation To Present At The J.P. Morgan Healthcare Conference

CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W.

CONMED Announces Definitive Agreement To Acquire Buffalo Filter LLC

CONMED Announces Definitive Agreement To Acquire Buffalo Filter LLC

CONMED Corporation (NASDAQ:CNMD) today announced a definitive agreement to acquire privately-held Buffalo Filter LLC (Buffalo Filter) for $365 million on a cash-free, debt-free basis.

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation (NASDAQ: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.

CONMED Corporation To Present At The Jefferies London Healthcare Conference

CONMED Corporation To Present At The Jefferies London Healthcare Conference

CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W.

CONMED Corporation Announces Third Quarter 2018 Financial Results

CONMED Corporation Announces Third Quarter 2018 Financial Results

CONMED Corporation (Nasdaq: CNMD) today announced financial results for the third quarter ended September 30, 2018.

CONMED Corporation To Announce Third Quarter 2018 Financial Results On November 1, 2018

CONMED Corporation To Announce Third Quarter 2018 Financial Results On November 1, 2018

CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the third quarter of fiscal year 2018 after the market close on Thursday, November 1, 2018.

CONMED Corporation To Present At The Morgan Stanley Global Healthcare Conference

CONMED Corporation To Present At The Morgan Stanley Global Healthcare Conference

CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W.

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation (NASDAQ: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.

CONMED Corporation Announces Second Quarter 2018 Financial Results

CONMED Corporation Announces Second Quarter 2018 Financial Results

CONMED Corporation (Nasdaq: CNMD) today announced financial results for the second quarter ended June 30, 2018.

CONMED Corporation To Announce Second Quarter 2018 Financial Results On August 1, 2018

CONMED Corporation To Announce Second Quarter 2018 Financial Results On August 1, 2018

CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the second quarter of fiscal year 2018 after the market close on Wednesday, August 1, 2018.

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation (NASDAQ:CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.

CONMED Corporation Announces First Quarter 2018 Financial Results

CONMED Corporation Announces First Quarter 2018 Financial Results

CONMED Corporation (Nasdaq: CNMD) today announced financial results for the first quarter ended March 31, 2018.

CONMED Corporation To Present At Two Investor Conferences In May

CONMED Corporation To Present At Two Investor Conferences In May

CONMED Corporation (NASDAQ:CNMD) today announced that it will present at the following two investor conferences in May.

CONMED Corporation To Announce First Quarter 2018 Financial Results On April 25, 2018

CONMED Corporation To Announce First Quarter 2018 Financial Results On April 25, 2018

CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the first quarter of fiscal year 2018 after the market close on Wednesday, April 25, 2018.

Conmed Reaches Analyst Target Price

Conmed Reaches Analyst Target Price

In recent trading, shares of Conmed Corp. have crossed above the average analyst 12-month target price of $62.50, changing hands for $63.31/share.

CONMED Corporation Announces Annual Meeting Of Shareholders

CONMED Corporation Announces Annual Meeting Of Shareholders

CONMED Corporation (NASDAQ:CNMD) today announced that its Annual Meeting of Shareholders will be held at the Company's corporate offices, 525 French Road, Utica, NY on Wednesday, May 23, 2018, at 2:00 p.

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation (NASDAQ:CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.

CONMED Corporation To Present At The Canaccord Genuity Musculoskeletal Conference

CONMED Corporation To Present At The Canaccord Genuity Musculoskeletal Conference

CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W.

CONMED Corporation To Present At The Leerink Partners 7th Annual Global Healthcare Conference

CONMED Corporation To Present At The Leerink Partners 7th Annual Global Healthcare Conference

CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W.

CONMED Corporation Announces Fourth Quarter And Fiscal Year 2017 Financial Results

CONMED Corporation Announces Fourth Quarter And Fiscal Year 2017 Financial Results

CONMED Corporation (Nasdaq:CNMD) today announced financial results for the fourth quarter and fiscal year ended December 31, 2017.

CONMED Corporation To Announce Fourth Quarter And Fiscal Year 2017 Financial Results On January 31, 2018

CONMED Corporation To Announce Fourth Quarter And Fiscal Year 2017 Financial Results On January 31, 2018

CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the fourth quarter and fiscal year 2017 after the market close on Wednesday, January 31, 2018.

CNMD Crosses Above Average Analyst Target

CNMD Crosses Above Average Analyst Target

In recent trading, shares of Conmed Corp. have crossed above the average analyst 12-month target price of $53.50, changing hands for $54.14/share.

TheStreet Quant Rating: A+ (Buy)